Skip to main content


Common Name(s): Pectin

Medically reviewed by Last updated on May 22, 2023.

Clinical Overview


Pectin has been used in antidiarrheal products and to lower blood lipoprotein levels. Pectin also has been investigated for its effects on cancer, diabetes, and gastroesophageal reflux disease/gastric ulceration. However, quality clinical trials are lacking.


Pectin and/or modified pectin have been used in clinical studies in doses of 10 to 20 g daily.


Contraindications have not yet been identified.


Information regarding safety and efficacy in pregnancy and lactation is lacking.


Coadministration of pectin with beta-carotene–containing foods or supplements can reduce blood levels of beta-carotene by more than 50%.

Pectin may decrease the serum concentration of cardiac glycosides, quinidine, and trimethoprim and the absorption of lincosamide. Pectin may diminish the therapeutic effect of lovastatin.

Adverse Reactions

Pectin is generally well tolerated when ingested. Occupational asthma has been associated with the inhalation of pectin dust. A cross-sensitivity to cashew and pistachio nuts may exist.


No major toxicities have been reported with the use of pectin.


Pectin is found in the cell walls of all plant tissue, where it acts as an intercellular cement, giving the plant structural rigidity. The compound is found at concentrations of 15% to 30% in the fiber of fruits, vegetables, legumes, and nuts.1 Lemon and orange rinds are among the richest sources of pectin, containing up to 30% of this polysaccharide.2 Pectin is also found in the roots of most plants. 3

French scientists Henri Braconnot and Anselme Payen were the first to discover pectins in 1825.4, 5 Braconnot named it "pectic acid," based on an ancient Greek word meaning "coagulant."4 Pectin has been used in the food industry to add body and texture to jellies, jams, puddings, and other gelatinous products. It has also been added to antidiarrheal products and has been particularly effective when combined with adsorbing clays, such as kaolin.


Pectins are polysaccharides with a molecular weight range from 20,000 to 400,000 daltons, depending on the number of carbohydrate monomers.2 Pectin is a fermentable fiber that results in the production of short-chain fatty acids and methane.6, 7 The simplest type of pectin is a linear polymer of galacturonic acid, a water-soluble viscous fiber8, 9 that is connected with alpha (1→4) bonds.9 More complex pectins are formed by linked D-polygalacturonate and L-rhamnose residues. The neutral sugars D-galactose, L-arabinose, D-xylose, and L-fucose may form side chains on some pectin molecules. Once extracted, pectin occurs as a coarse or fine yellowish powder that is highly water soluble and forms thick colloidal solutions. In the presence of calcium ions, pectin forms a gel that is more resistant to disruption in the gut than alginate gel.3 Additionally, when there is a low degree of esterification, the mucoadhesive capacity of pectin is important along the GI tract.10 The parent compound, protopectin, is insoluble but is readily converted by hydrolysis into pectinic acids (also known generically as pectins).11

Pectin that has been pH-modified into smaller, less complex molecules is called modified citrus pectin. This modification allows better dissolution in water and more complete absorption by the body.12

Uses and Pharmacology


The association between pectin's complex structure and its activity against cancer is difficult to assess because of differences in origin and chemical modifications to pectin used in studies are not well described.4 Dietary fiber has been associated with a reduction in the risk of colon cancer4; however, this association has been questioned in a pooled analysis of prospective cohort studies.13 After accounting for other dietary risk factors, no association with a lowered risk of colorectal cancer was found, and analysis of specific food sources also found no association.13

Modified pectin has been evaluated for efficacy in cancer treatment. The mechanisms by which pectins may exert their effect include the ability to bind to cancer cell surface galectins (galactose-binding lectins), causing mitochondrial disruption, enhancing response to chemotherapy, and impeding metastasis.4, 14, 15, 16, 17, 18, 19, 20 Consequent interference with cell-cell or cell-matrix adhesion and induction of apoptosis has been described.15 Pectin-derived galectin-3 receptor binding agents (GBC-590 and GCS-100) have entered phase 2 trials.14, 17

Animal/In vitro data

Modified citrus pectin was studied in a rat model of prostate cancer metastasis. Although primary tumor growth was not affected, metastasis was reduced when compared with control.21 In mice with either human breast cancer cells or human colon cancer cells, modified citrus pectin was found to decrease tumor growth and weight, angiogenesis, and metastasis.20 In vitro experiments have demonstrated the efficacy of modified pectin in inducing apoptosis in human prostate cell lines15 and inhibiting cell proliferation in skin, colon, lung, and melanoma lines.22

Clinical data

A nonrandomized intervention study using modified citrus pectin demonstrated a statistically significant increase in prostate-specific antigen (PSA)–doubling time in 7 of 10 patients with refractory prostate cancer.12, 16 Survival times were not measured in this study, but a slowing of disease progression was postulated based on the increase in PSA-doubling time. Phase 2 trials have evaluated the effect of pectin-derived galectin-3 receptor binding agents in refractory or relapsed colorectal and pancreatic cancer, reporting tumor stabilization and reduction of tumor growth in some patients.14, 17


Animal/In vitro data

In a study of Zucker rats, fatty rats fed a 10% methoxylated pectin-based diet experienced a reduction in triglyceride levels as well as an increase in high-density lipoprotein (HDL) cholesterol levels.23

Clinical data

Despite many large trials evaluating the effect of dietary fiber on cardiovascular outcomes, few have specifically investigated the role of pectin, and controversy remains regarding its efficacy in affecting the lipid profile.24, 25, 26, 27 Most studies have evaluated pectin in combination with other gums and results have varied, with some showing decreases in total cholesterol level and triglycerides (although HDL cholesterol levels remained unaffected) and others failing to demonstrate lower cholesterol in hypercholesterolemic patients.28, 29, 30, 31, 32 Results have also varied in trials evaluating the effect of pectin alone on serum lipids.25, 33, 34, 35, 36 A meta-analysis of the cholesterol-lowering effects of dietary fiber (comparison of pectin, oat bran, guar gum, and psyllium) showed that increasing soluble fiber may make only a small contribution to lowering cholesterol.27 Results from 1 clinical trial found that pectin source and characteristics such as degree of esterification impacted cholesterol-lowering ability. Citrus and apple pectins with a higher degree of esterification were more effective than pectins from the same source with lower esterification, and citrus and apple pectins lowered cholesterol more effectively than orange pulp fiber pectin.37 Mechanisms of action have been investigated and include an ability to protect against low-density lipoprotein (LDL) peroxidation,38, 39 upregulation of HDL metabolism,26 and a higher water-holding capacity of pectin compared with cereals or bran.26 The 2017 joint position statement of the Italian Society of Diabetology (ISD) and the Italian Society for the Study of Arteriosclerosis (ISSA) on nutraceuticals for the treatment of hypercholesterolemia strongly recommends the use of fiber (eg, oat beta-glucan, chitosan, glucomannan, guar gum, HPMC, pectin, psyllium) to lower LDL in the general population that fails to increase dietary fiber; in patients with mild hypercholesterolemia and low to moderate cardiovascular risk; or in patients with mild hypercholesterolemia and metabolic syndrome (Level I, Strength A).84 Systolic blood pressure decreased in adults treated with pectin versus placebo in a double-blind, randomized clinical trial,33 whereas hypertension remained unaltered in another study.40 No significant changes were seen for inflammatory markers of high-sensitivity C-reactive protein or homocysteine in 1 clinical trial.37 Apple pectin was similar to aspirin for reduction in severity and duration, but not incidence, of niacin-induced flushing.41

Chelating effects

Animal/In vitro data

In an in vitro model, calcium pectate exhibited metal-binding properties.42 In a study of rats, lead accumulation in organs such as the kidneys, liver, and heart was reduced with calcium pectate administration. Lead accumulation was also reduced in the femur.42

Clinical data

Modified citrus pectin 15 g/day significantly increased the urinary excretion of arsenic, cadmium, and lead in adults with a normal metal load) after 6 days of administration,43 a chelating effect attributed to the presence of rhamnogalacturonan in pectin.43 In children from Belarus with moderate and high cesium loads, the administration of apple-derived pectin (Vitapect) 10 g/day reduced cesium levels.40, 44 Beneficial effects on the antioxidant level of hematologic systems have also been demonstrated.45


Animal/In vitro data

In a study of Zucker rats, fatty rats fed a highly methoxylated pectin diet experienced a reduction in blood glucose starting at the third study week. By the end of the study, there were no differences between the fatty rats receiving the pectin-based diet and lean rats. Additionally, fatty rats receiving the pectin-based diet had reduced plasma insulin concentrations comparable with those in the lean rats.23

Clinical data

Meals high in soluble fiber have increased satiety and reduced the rise in postprandial blood glucose and insulin concentrations.25, 46 However, the few trials specifically evaluating the effect of pectin on markers of diabetes have been less convincing. No change in fasting plasma glucose levels and no effect on postprandial glucose response were noted in healthy adults or adults with dietary-controlled type 2 diabetes,33, 47 whereas hypoglycemic actions were demonstrated in nondiabetic patients with hyperlipidemia.36



Animal/In vitro data

In a murine model, rats with short bowel syndrome receiving an enteral diet supplemented with 2% citrus pectin after resection experienced less weight loss, an increase in the solidity of the stool, and increased water absorption in the colon.48

Clinical data

Pectin has been used in the management of diarrhea for many years. It stimulates epithelial growth in the colon, thus reducing diarrhea.49 Pectin supplementation was as effective as green bananas in the management of persistent diarrhea in children. Both pectin and banana reduced the volume of stool, improved stool quality, decreased the amount of oral replacement solutions and intravenous fluids for hydration needed, and shortened the duration of illness.50, 51 In a study of 44 critically ill, tube-fed adults receiving antibiotics, there was a trend toward decreased diarrhea in those receiving fiber and pectin. Pectin stimulates epithelial growth in the colon, thus reducing diarrhea.49 Another suggested mechanism of action in the GI tract is the effect of peptic oligosaccharides on the intestinal microflora.52, 53, 54 A very small study in patients with short bowel syndrome found nonsignificant increases in gastric emptying and orocolonic transit times with pectin ingestion.6

In the 2006 DIALOG II study, a placebo-controlled, double-blind study in children evaluating the efficacy of an apple pectin–chamomile extract, in the treatment of acute diarrhea, 241 children between 6 months and 6 years of age received the extract (dosed according to the child’s age) or placebo for 5 days at the onset diarrhea. The frequency of stools was reduced in patients receiving treatment compared with those receiving placebo on days 3 and 5.55

Gastroesophageal reflux/gastric ulceration

Animal data/In vitro data

In a study of horses, a commercial feed supplement containing pectin and lecithin, among other components (Egusin), was found to reduce the severity of gastric ulceration in feed-deprived, stall-confined horses after 35 days of administration.56

Clinical data

A pectin-based, raft-forming, antireflux agent available in Europe has been studied for use in patients with heartburn. This product reduces the amount of food and acid concentration that reaches the esophagus, reducing heartburn.57, 58, 59 The pectin-based agent also delayed the recurrence of moderate or severe heartburn and erosive esophagitis when used as maintenance treatment.60 However, in a study of patients with an ileal pouch–anal anastomosis, neither pectin nor fiber had any effect on stool frequency.61 Gastric emptying rate increased with coadministration of pectin in an experiment in healthy adults.62 Additionally, pectin combined with liquid nutrients was found to be effective prophylaxis against gastroesophageal reflux in elderly patients receiving feedings via percutaneous endoscopic gastrostomy.63

In a 2012 clinical study of 18 children with cerebral palsy and gastroesophageal reflux symptoms (chronic cough, vomiting, laryngitis, and pH levels less than 4), a high-pectin diet was found to decrease the medium percentage time for the pH to fall below 4, the number of reflux episodes per day, the duration of longest reflux, the number of vomiting episodes, and the median cough score.64

Other uses

Drug delivery systems

An alginate-pectin-polylysine combination has shown promise as a vehicle for controlled-release medications. The presence of a rigid pectin gel inside the particulates imparts a stronger and more stable vehicle in acidic and alkaline solutions, which could prolong drug release. This particulate system may have potential use as a carrier for drugs that are poorly absorbed after oral administration.3, 65


Plants such as Comarum palustre, Glinus oppositifolus, Vernonia kotschyana, and Bergenia crassifola and pectic polysaccharides, including arabinogalactin, rhamnogalacturonan, and comaruman, originating in various plants used in traditional medicine have been evaluated for their effect on the immune system.66, 67, 68, 69, 70, 71 Various actions have been described from in vitro experiments, including interference with neutrophil adhesion, complement-fixing actions, and upregulation of cytokine secretion. The immunomodulatory effects of pectin depend on the structure of the backbone and branched regions of the polysaccharide.5


Galacto-oligosaccharides have been evaluated for their preventive effect on food sensitization in infants. Insufficient data exist to support or refute a use for prebiotic supplementation to prevent food allergy.72 Although pectin may have a physical influence on the digestion of food proteins as allergens,73 an allergy to pectin itself has been reported.74


Pectin and/or modified pectin have been used in clinical studies of cholesterol reduction at doses of 10 to 20 g daily.29, 35, 37, 40, 43

Pregnancy / Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking.


Coadministration of pectin with beta-carotene–containing foods or supplements can reduce beta-carotene blood levels by more than 50%.(75) There is some evidence that concomitant ingestion of pectin with high-energy diets may reduce the nutritional benefits of these diets, as demonstrated in a controlled trial of undernourished children; urea production was also lower in children who ingested pectin with a caloric supplement.(76)

Cardiac glycosides: Pectin may decrease the serum concentration of cardiac glycosides. Monitor therapy. Only oral preparations of cardiac glycosides are expected to participate in this interaction.(85, 86, 87, 88)

Lincosamide antibiotics: Pectin may decrease the absorption of lincosamide antibiotics. Monitor therapy. This interaction only applies to oral administration of lincosamide antibiotics.(89, 90)

Lovastatin: Pectin may diminish the therapeutic effect of lovastatin. Monitor therapy.(77)

Quinidine: Pectin may decrease the serum concentration of quinidine. Monitor therapy. Only oral preparations of quinidine and pectin are expected to participate in this interaction.(91)

Trimethoprim: Pectin may decrease the serum concentration of trimethoprim. No action needed. This interaction only applies to oral administration of trimethoprim.(92)

Adverse Reactions

Occupational asthma associated with the inhalation of pectin dust is a well-recognized hazard.78, 79, 80, 81 Positive skin test results for pectin suggest an immunoglobulin E–mediated hypersensitivity reaction.81 Case reports of allergy (anaphylaxis) to pectin and cross-reactivity to cashews and pistachios exist.74, 82

Doses of pectin 50 to 100 mg/kg in rats increased the number of gastric mucosal lesions produced by ethanol or aspirin, no increase was produced by application of pectin 25 mg/kg.83 Whether these pectin-induced physicochemical changes are reproducible in humans has yet to be studied.


No major toxicities have been reported with the use of pectin.



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

1. Marlett JA. Content and composition of dietary fiber in 117 frequently consumed foods. J Am Diet Assoc. 1992;92(2):175-186.1310700
2. Windholz M, ed. The Merck Index, 10th ed. Rahway, NJ: Merck & Co; 1983.
3. Liu P, Krishnan TR. Alginate-pectin-poly-L-lysine particulate as a potential controlled release formulation. J Pharm Pharmacol. 1999;51(2):141-149.10217312
4. Leclere L, Cutsem PV, Michiels C. Anti-cancer activities of pH- or heat-modified pectin. Front Pharmacol. 2013;4:128.24115933
5. Popov SV, Ovodov YS. Polypotency of the immunomodulatory effect of pectins. Biochemistry (Mosc). 2013;78(7):823-835.24010844
6. Atia A, Girard-Pipau F, Hébuterne X, et al. Macronutrient absorption characteristics in humans with short bowel syndrome and jejunocolonic anastomosis: starch is the most important carbohydrate substrate, although pectin supplementation may modestly enhance short chain fatty acid production and fluid absorption. JPEN J Parenter Enteral Nutr. 2011;35(2):229-240.21378253
7. Mortensen PB, Nordgaard-Andersen I. The dependence of the in vitro fermentation of dietary fibre to short-chain fatty acids on the contents of soluble non-starch polysaccharides. Scand J Gastroenterol. 1993;28(5):418-422.8390090
8. Bazzano LA. Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk. Curr Atheroscler Rep.2008;10(6):473-477.18937894
9. Lattimer JM, Haub MD. Effects of dietary fiber and its components on metabolic health. Nutrients. 2010;2(12):1266-1289.22254008
10. Wikiera A, Irla M, Mika M. Health-promoting properties of pectin [in Polish]. Postepy Hig Med Dosw (Online). 2014;68:590-596.24864109
11. Evans WC. Trease and Evans' Pharmacognosy. 13th ed. London, England: Balliére Tindall; 1989.
12. Strum SB, Scholz M, McDermed J, McCulloch M, Eliaz I. Modified citrus pectin slows PSA doubling time: a pilot clinical trial. Paper presented at: International Conference on Diet and Prevention of Cancer; May 28-June 2, 1999; Tampere, Finland.
13. Park Y, Hunter DJ, Spiegelman D, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA. 2005;294(22):2849-2857.16352792
14. Cotter FE. Unraveling biologic therapy for Bcl-2-expressing malignancies. Semin Oncol. 2004;31(6 suppl 16):18-21; discussion 33.15799240
15. Jackson CL, Dreaden TM, Theobald LK, et al. Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structure. Glycobiology. 2007;17(8):805-819.17513886
16. Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis. 2003;6(4):301-304.14663471
17. Günzburg WH, Salmons B. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer. Acta Biochim Pol. 2005;52(3):601-607.16175235
18. Sathisha UV, Jayaram S, Harish Nayaka MA, Dharmesh SM. Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources. Glycoconj J. 2007;24(8):497-507.17525829
19. Glinsky VV, Raz A. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr Res. 2009;344(14):1788-1791.1906199210.1016/j.carres.2008.08.038
20. Nangia-Makker P, Hogan V, Honjo Y, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002;94(24):1854-1862.12488479
21. Pienta KJ, Naik H, Akhtar A, et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995;87(5):348-353.7853416
22. Kang HJ, Jo C, Kwon JH, Son JH, An BJ, Byun MW. Antioxidant and cancer cell proliferation inhibition effect of citrus pectin-oligosaccharide prepared by irradiation. J Med Food. 2006;9(3):313-320.17004892
23. Sánchez D, Muguerza B, Moulay L, Hernandez R, Miguel M, Aleixandre A. Highly methoxylated pectin improves insulin resistance and other cardiometabolic risk factors in Zucker fatty rats. J Agric Food Chem. 2008;56(10):3574-3581.18433105
24. Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol. 2002;39(1):49-56.11755286
25. Zhang C, Liu S, Solomon CG, Hu FB. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care. 2006;29(10):2223-2230.17003297
26. Wu H, Dwyer KM, Fan Z, Shircore A, Fan J, Dwyer JH. Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr. 2003;78(6):1085-1091.14668268
27. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1):30-42.9925120
28. Biesenbach G, Grafinger P, Janko P, Kaiser W, Stuby U, Moser E. The lipid lowering effect of a new guar-pectin fiber mixture in type II diabetic patients with hypercholesterolemia [in German]. Leber Magen Darm. 1993;23(5):204, 207-209.8412469
29. Knopp RH, Superko HR, Davidson M, et al. Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med. 1999;17(1):18-23.10429748
30. Hosobuchi C, Rutanassee L, Bassin SL, Wong ND. Efficacy of acacia, pectin, and guar gum-based fiber supplementation in the control of hypercholesterolemia. Nutr Res. 1999;19(5):643-649.
31. Jensen CD, Haskell W, Whittam JH. Long-term effects of water-soluble dietary fiber in the management of hypercholesterolemia in healthy men and women. Am J Cardiol. 1997;79(1):34-37.9024732
32. Davidson MH, Dugan LD, Stocki J, et al. A low-viscosity soluble-fiber fruit juice supplement fails to lower cholesterol in hypercholesterolemic men and women. J Nutr. 1998;128(11):1927-1932.9808644
33. Schwab U, Louheranta A, Törrönen A, Uusitupa M. Impact of sugar beet pectin and polydextrose on fasting and postprandial glycemia and fasting concentrations of serum total and lipoprotein lipids in middle-aged subjects with abnormal glucose metabolism. Eur J Clin Nutr. 2006;60(9):1073-1080.16523204
34. Sheehan JP, Wei IW, Ulchaker M, Tserng KY. Effect of high fiber intake in fish oil-treated patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1997;66(5):1183-1187.9356537
35. Veldman FJ, Nair CH, Vorster HH, et al. Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects. Thromb Res. 1997;86(3):183-196.9175240
36. Wolfram RM, Kritz H, Efthimiou Y, Stomatopoulos J, Sinzinger H. Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hyperlipidemia—a pilot study. Wien Klin Wochenschr. 2002;114(19-20):840-846.12503475
37. Brouns F, Theuwissen E, Adam A, Bell M, Berger A, Mensink RP. Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women. Eur J Clin Nutr. 2012;66(5):591-599.22190137
38. Yang SS, Cheng KT, Lin YS, Liu YW, Hou WC. Pectin hydroxamic acids exhibit antioxidant activities in vitro. J Agric Food Chem. 2004;52(13):4270-4273.15212479
39. Lewińska D, Rosiński S, Piatkiewicz W. A new pectin-based material for selective LDL-cholesterol removal. Artif Organs. 1994;18(3):217-222.8185488
40. Bandazhevskaya GS, Nesterenko VB, Babenko VI, Yerkovich TV, Bandazhevsky YI. Relationship between caesium (137Cs) load, cardiovascular symptoms, and source of food in 'Chernobyl' children—preliminary observations after intake of oral apple pectin. Swiss Med Wkly. 2004;134(49-50):725-729.15635491
41. Moriarty PM, Backes J, Dutton JA, He J, Ruisinger JF, Schmelzle K. Apple pectin for the reduction of niacin-induced flushing. J Clin Lipidol. 2013;7(2):140-146.23415433
42. Khotimchenko M, Sergushchenko I, Khotimchenko Y. Lead absorption and excretion in rats given insoluble salts of pectin and alginate. Int J Toxicol. 2006;25(3):195-203.16717035
43. Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006;20(10):859-864.16835878
44. Nesterenko VB, Nesterenko AV, Babenko VI, Yerkovich TV, Babenko IV. Reducing the 137Cs-load in the organism of "Chernobyl" children with apple-pectin. Swiss Med Wkly. 2004;134(1-2):24-27.14745664
45. Bereza Vla, Chaialo PP, Iatsula GS, Shimelis IV, Protas AF. Pectin-containing products in the dietary nutrition of subjects exposed to ionizing radiation as a result of the accident at the Chernobyl Atomic Electric Power Station [in Russian]. Lik Sprava. 1993;(8):21-24.8079467
46. Perrigue M, Carter B, Roberts SA, Drewnowski A. A low-calorie beverage supplemented with low-viscosity pectin reduces energy intake at a subsequent meal. J Food Sci. 2010;75(9):H300-H305.21535604
47. Sanaka M, Yamamoto T, Anjiki H, Nagasawa K, Kuyama Y. Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers. Clin Exp Pharmacol Physiol. 2007;34(11):1151-1155.17880369
48. Roth JA, Frankel WL, Zhang W, Klurfeld DM, Rombeau JL. Pectin improves colonic function in rat short bowel syndrome. J Surg Res. 1995;58(2):240-246.7861779
49. Schultz AA, Ashby-Hughes B, Taylor R, Gillis DE, Wilkins M. Effects of pectin on diarrhea in critically ill tube-fed patients receiving antibiotics. Am J Crit Care. 2000;9(6):403-411.11072556
50. Rabbani GH, Teka T, Zaman B, Majid N, Khatun M, Fuchs GJ. Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children. Gastroenterology. 2001;121(3):554-560.11522739
51. Rabbani GH, Teka T, Saha SK, et al. Green banana and pectin improve small intestinal permeability and reduce fluid loss in Bangladeshi children with persistent diarrhea. Dig Dis Sci. 2004;49(3):475-484.15139502
52. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr. 2005;41(2):186-190.16056097
53. Olano-Martin E, Gibson GR, Rastell RA. Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides. J Appl Microbiol. 2002;93(3):505-511.12174051
54. Olano-Martin E, Williams MR, Gibson GR, Rastall RA. Pectins and pectic-oligosaccharides inhibit Escherichia coli O157:H7 Shiga toxin as directed towards the human colonic cell line HT29. FEMS Microbiol Lett. 2003;218(1):101-105.12583904
55. Becker B, Kuhn U, Hardewig-Budny B. Double-blind, randomized evaluation of clinical efficacy and tolerability of an apple pectin-chamomile extract in children with unspecific diarrhea. Arzneimittelforschung.2006;56(6):387-393.16889120
56. Woodward MC, Huff NK, Garza F Jr, Keowen ML, Kearney MT, Andrews FM. Effect of pectin, lecithin, and antacid feed supplements (Egusin) on gastric ulcer scores, gastric fluid pH and blood gas values in horses. BMC Vet Res. 2013;10(suppl 1):S4.25238454
57. Waterhouse ET, Washington C, Washington N. An investigation into the efficacy of the pectin based anti-reflux formulation-Aflurax. Int J Pharm. 2000;209(1-2):79-85.11084248
58. Havelund T, Aalykke C. The efficacy of a pectin-based raft-forming anti-reflux agent in endoscopy-negative reflux disease. Scand J Gastroenterol. 1997;32(8):773-777.9282968
59. Kapadia CJ, Mane VB. Raft-forming agents: antireflux formulations. Drug Dev Ind Pharm. 2007;33(12):1350-1361.18097809
60. Havelund T, Aalykke C, Rasmussen L. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol. 1997;9(5):509-514.9187886
61. Thirlby RC, Kelly R. Pectin and methyl cellulose do not affect intestinal function in patients after ileal pouch-anal anastomosis. Am J Gastroenterol. 1997;92(1):99-102.8995946
62. Shimoyama Y, Kusano M, Kawamura O, et al. High-viscosity liquid meal accelerates gastric emptying. Neurogastroenterol Motil. 2007;19(11):879-886.17973639
63. Miyazawa R, Tomomasa T, Kaneko H, Arakawa H, Shimizu N, Morikawa A. Effects of pectin liquid on gastroesophageal reflux disease in children with cerebral palsy. BMC Gastroenterol. 2008;8:11.18412980
64. Adachi K, Furuta K, Aimi M, et al. Efficacy of pectin solution for preventing gastro-esophageal reflux events in patients with percutaneous endoscopic gastrostomy. J Clin Biochem Nutr. 2012;50(3):190-194.22573919
65. Madziva H, Kailasapathy K, Phillips M. Alginate-pectin microcapsules as a potential for folic acid delivery in foods. J Microencapsul. 2005;22(4):343-351.16214783
66. Popov SV, Ovodova RG, Popova GY, Nikitina IR, Ovodov YS. Adhesion of human neutrophils to fibronectin is inhibited by comaruman, pectin of marsh cinquefoil Comarum palustre L., and by its fragments. Biochemistry (Mosc). 2005;70(1):108-112.15701056
67. Popov SV, Popova GY, Nikolaeva SY, Golovchenko VV, Ovodova RG. Immunostimulating activity of pectic polysaccharide from Bergenia crassifolia (L.) Fritsch. Phytother Res. 2005;19(12):1052-1056.16372372
68. Inngjerdingen KT, Patel TR, Chen X, et al. Immunological and structural properties of a pectic polymer from Glinus oppositifolius. Glycobiology. 2007;17(12):1299-1310.17726087
69. Nergard CS, Matsumoto T, Inngjerdingen M, et al. Structural and immunological studies of a pectin and a pectic arabinogalactan from Vernonia kotschyana Sch. Bip. ex Walp. (Asteraceae). Carbohydr Res. 2005;340(1):115-130.15620674
70. Szu SC, Bystricky S. Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella typhi. Methods Enzymol. 2003;363:552-567.14579603
71. Kiyohara H, Matsumoto T, Nagai T, Kim SJ, Yamada H. The presence of natural human antibodies reactive against pharmacologically active pectic polysaccharides from herbal medicines. Phytomedicine. 2006;13(7):494-500.16427263
72. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev. 2007;(4):CD006475.17943912
73. Polovic N, Blanusa M, Gavrovic-Jankulovic M, et al. A matrix effect in pectin-rich fruits hampers digestion of allergen by pepsin in vivo and in vitro. Clin Exp Allergy. 2007;37(5):764-771.17456224
74. Ferdman RM, Ong PY, Church JA. Pectin anaphylaxis and possible association with cashew allergy. Ann Allergy Asthma Immunol. 2006;97(6):759-760.17201234
75. Rock CL, Swendseid ME. Plasma beta-carotene response in humans after meals supplemented with dietary pectin. Am J Clin Nutr. 1992;55(1):96-99.1309477
76. Doherty J, Jackson AA. The effect of dietary pectin on rapid catch-up weight gain and urea kinetics in children recovering from severe undernutrition. Acta Paediatr. 1992;81(6-7):514-517.1392364
77. Richter WO, Jacob BG, Schwandt P. Interaction between fibre and lovastatin. Lancet. 1991;338(8768):706.1679514
78. Baldwin JL, Shah AC. Pectin-induced occupational asthma. Chest. 1993;104(6):1936-1937.8252999
79. Cohen AJ, Forse MS, Tarlo SM. Occupational asthma caused by pectin inhalation during the manufacture of jam. Chest. 1993;103(1):309-311.8417915
80. Kraut A, Peng Z, Becker AB, Warren CP. Christmas candy maker's asthma. IgG4-mediated pectin allergy. Chest. 1992;102(5):1605-1607.1424903
81. Jaakkola MS, Tammivaara R, Tuppurainen M, Lahdenne L, Tupasela O, Keskinen H. Asthma caused by occupational exposure to pectin. J Allergy Clin Immunol. 1997;100(4):575-576.9338555
82. Räsänen L, Mäkinen-Kiljunen S, Harvima RJ. Pectin and cashew nut allergy: cross-reacting allergens? Allergy. 1998;53(6):626-628.9689352
83. Figler M, Mozsik G. Effect of pectin application on gastric mucosal lesions induced by ethanol or aspirin in rats [abstract A13]. Dig Dis Sci. 1998;43:2342.
84. Pirro M, Vetrani C, Bianchi C, Mannarino MR, Bernini F, Rivellese AA. Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). Nutr Metab Cardiovasc Dis. 2017;27(1):2-17.27956024
85. Albert KS, Elliott WJ, Abbott RD, et al. Influence of kaolin-pectin on steady-state digoxin levels. J Clin Pharmacol. 1981;21:449-455.7309406
86. Brown DD, Juhl RP. Decreased bioavailability of digoxin due to antacids and kaolin-pectin. N Engl J Med. 1976;295(19):1034-1037.972657
87. Albert KS, Ayres JW, Disanto AR, et al. Influence of kaolin-pectin suspension on digoxin bioavailability. J Pharm Sci. 1978;67:1582-1586.712596
88. Allen MD, Greenblatt DJ, Harmatz JS, Smith, TW. Effect of magnesium aluminum hydroxide and kaolin-pectin on absorption of digoxin from tablets and capsules. J Clin Pharmacol. 1981;21:26-30.7012189
89. Albert KS, DeSante KA, Welch RD, et al. Pharmacokinetic evaluation of a drug interaction between kaolin-pectin and clindamycin. J Pharm Sci. 1978;67(11):1579-1582.712595
90. KAPECT (kaolin and pectin) suspension [Qatar product information]. 10th of Ramadan City, Egypt: E.I.P.I. CO.; November 2010.
91. Moustafa MA, Al-Shora HI, Gaber M, et al. Decreased bioavailability of quinidine sulphate due to interactions with adsorbent antacids and antidiarrhoeal mixtures. Int J Pharm. 1987;34:207-211.
92. Gupta KC, Desai NK, Satoskar RS, Gupta C, Goswanmi SN. Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension. Int J Clin Pharmacol Ther Toxicol. 1987;25(6):320-321.3497885

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.